Peds Clinical Cases (Egypt) 3-09 (Final Version)

download Peds Clinical Cases (Egypt) 3-09 (Final Version)

of 57

Transcript of Peds Clinical Cases (Egypt) 3-09 (Final Version)

  • 8/14/2019 Peds Clinical Cases (Egypt) 3-09 (Final Version)

    1/57

    Interesting PediatricRespiratory Cases:

    An Interactive Discussion

    Interesting PediatricRespiratory Cases:

    An Interactive Discussion

    Ira M. Cheifetz, MD, FCCM, FAARCProfessor of PediatricsChief, Pediatric Critical Care

    Medical Director, PICUDuke Childrens Hospital

    Ira M. Cheifetz, MD, FCCM, FAARCIra M. Cheifetz, MD, FCCM, FAARC

    Professor of PediatricsProfessor of PediatricsChief, Pediatric Critical CareChief, Pediatric Critical Care

    Medical Director, PICUMedical Director, PICUDuke ChildrenDuke Childrens Hospitals Hospital

  • 8/14/2019 Peds Clinical Cases (Egypt) 3-09 (Final Version)

    2/57

    Case 1: PneumoniaCase 1: Pneumonia Previously healthy 4 yo (18 kg) girl presents

    with a 5 day h/o URI symptoms, cough, & fever Admitted to the pediatric ward with RLL

    pneumonia

    Over 48 hours, she develops worseningtachypnea, progressive bilateral infiltrates, and

    hypoxia

    HR 152, RR 42, SpO2 89% (2 lpm), T 39.5C

    Diffuse rales, mod subcostal retractions

    Previously healthy 4 yo (18 kg) girl presents

    with a 5 day h/o URI symptoms, cough, & fever

    Admitted to the pediatric ward with RLL

    pneumonia

    Over 48 hours, she develops worseningtachypnea, progressive bilateral infiltrates, and

    hypoxia

    HR 152, RR 42, SpOHR 152, RR 42, SpO22 89% (2 lpm), T 39.589% (2 lpm), T 39.5CC

    Diffuse rales, mod subcostal retractionsDiffuse rales, mod subcostal retractions

  • 8/14/2019 Peds Clinical Cases (Egypt) 3-09 (Final Version)

    3/57

  • 8/14/2019 Peds Clinical Cases (Egypt) 3-09 (Final Version)

    4/57

    Your AssessmentYour Assessment Moderate subcostal retractions, no

    supraclavicular retractions, good air exchange

    except at R base

    Significant crackles on right, minimal crackles

    on left, no wheezing

    SpO2 85% on 2 lpm via nasal cannulae

    CV normal pulses and capillary refill Exam otherwise unremarkable

    Moderate subcostal retractions, no

    supraclavicular retractions, good air exchange

    except at R base

    Significant crackles on right, minimal crackles

    on left, no wheezing

    SpOSpO22 85% on 2 lpm via nasal cannulae85% on 2 lpm via nasal cannulae

    CV normal pulses and capillary refill Exam otherwise unremarkable

  • 8/14/2019 Peds Clinical Cases (Egypt) 3-09 (Final Version)

    5/57

    Case ProgressionCase Progression Patient is transported to the Pediatric ICU

    Worsening respiratory distress

    Increased work of breathing

    RR 50s, SpO2 92% on 5 lpm

    Patient is transported to the Pediatric ICUPatient is transported to the Pediatric ICU

    Worsening respiratory distress

    Increased work of breathing

    RR 50s, SpO2 92% on 5 lpm

  • 8/14/2019 Peds Clinical Cases (Egypt) 3-09 (Final Version)

    6/57

    Question #1

    What would be your management?

    Question #1

    What would be your management?

    A. Observe closely

    B. CPAP

    C. Bilevel non-invasive ventilation (i.e., BiPAP)

    D. IntubateE. Hope that help arrives soon

    A.A. Observe closelyObserve closely

    B.B. CPAPCPAP

    C. Bilevel non-invasive ventilation (i.e., BiPAP)

    D.D. IntubateIntubateE.E. Hope that help arrives soonHope that help arrives soon

  • 8/14/2019 Peds Clinical Cases (Egypt) 3-09 (Final Version)

    7/57

    Non-invasive VentilationNon-invasive Ventilation Use of NIV for acute, hypoxic respiratory failureremains controversial

    intubation rate, ICU LOS, & ICU mortality Keenan, CCM, 2004 (meta-analysis)

    nosocomial pneumonia risk Hess, Respir Care, 2005 (meta-analysis)

    Use of NIV for acute, hypoxic respiratory failureUse of NIV for acute, hypoxic respiratory failure

    remains controversialremains controversial

    intubation rate, ICU LOS, & ICUintubation rate, ICU LOS, & ICU mortalitymortality Keenan, CCM, 2004 (metaKeenan, CCM, 2004 (meta--analysis)analysis)

    nosocomial pneumonia risknosocomial pneumonia risk Hess, Respir Care, 2005 (metaHess, Respir Care, 2005 (meta--analysis)analysis)

  • 8/14/2019 Peds Clinical Cases (Egypt) 3-09 (Final Version)

    8/57

    Case ProgressionCase Progression Patient is intubated the next morning for

    progressive hypoxia.

    PC/PS: rate 24 PIP 30 PEEP 12 FiO2 0.60

    ABG pH 7.3 PaCO2 55 PaO2 65

    PaO2 / FiO2 108

    Oxygenation index = 15

    OI = (MAP x FiO2) / PaO2

    Patient is intubated the next morning forPatient is intubated the next morning for

    progressive hypoxia.progressive hypoxia.

    PC/PS: rate 24 PIP 30 PEEP 12 FiOPC/PS: rate 24 PIP 30 PEEP 12 FiO22 0.600.60

    ABG pH 7.3 PaCO2 55 PaO2 65ABG pH 7.3 PaCO2 55 PaO2 65

    PaOPaO22 / FiO/ FiO22 108108 Oxygenation index = 15Oxygenation index = 15

    OI = (MAP x FiO2) / PaO2

  • 8/14/2019 Peds Clinical Cases (Egypt) 3-09 (Final Version)

    9/57

    Question #2

    What delivered tidal volume wouldyou choose?

    Question #2

    What delivered tidal volume wouldyou choose?

    A. 4 ml/kg

    B. 6 ml/kg

    C. 8 m/kg

    D. 10 ml/kg

    A. 4 ml/kg

    B. 6 ml/kg

    C. 8 m/kg

    D. 10 ml/kg

  • 8/14/2019 Peds Clinical Cases (Egypt) 3-09 (Final Version)

    10/57

    Low Tidal Volume Ventilation

    The appropriate Vt for pediatric acute lung

    injury has never been formally studied.

    Thus, the best we can do is extrapolate

    from data in the adult ARDS population.

    The appropriate Vt for pediatric acute lung

    injury has never been formally studied.

    Thus, the best we can do is extrapolate

    from data in the adult ARDS population.

    Volume 342(18) 4 May 2000 pp 1301-1308

    Ventilation with Lower Tidal Volumes as Compared with

    Traditional Tidal Volumes for Acute Lung Injury and theAcute Respiratory Distress Syndrome

  • 8/14/2019 Peds Clinical Cases (Egypt) 3-09 (Final Version)

    11/57

    13 Experts

    Yes: 5

    No: 8

    13 Experts

    Yes: 5

    No: 8

  • 8/14/2019 Peds Clinical Cases (Egypt) 3-09 (Final Version)

    12/57

    ARDS WorsensARDS Worsens Patient is transitioned to HFOV.

    MAP 28, Amp 59, 33% insp time, FiO2 0.70 pH 7.25, PaCO2 67, PaO2 65, SaO2 90%

    PaO2 / FiO2 93

    Oxygenation index = 30

    Patient is transitioned to HFOV.Patient is transitioned to HFOV.

    MAP 28, Amp 59, 33% insp time, FiOMAP 28, Amp 59, 33% insp time, FiO22 0.700.70 pH 7.25, PaCOpH 7.25, PaCO22 67, PaO67, PaO22 65, SaO65, SaO22 90%90%

    PaOPaO22 / FiO/ FiO22 9393

    Oxygenation index = 30Oxygenation index = 30

  • 8/14/2019 Peds Clinical Cases (Egypt) 3-09 (Final Version)

    13/57

    Question #3

    What should be the maximumacceptable PaCO2?

    Question #3

    What should be the maximumacceptable PaCO2?

    A. 55 torrB. 75 torr

    C. 95 torr

    D. Any PaCO2 as long as the pH is

    acceptable

    A.A. 55 torr55 torrB.B. 75 torr75 torr

    C.C. 95 torr95 torr

    D. Any PaCO2 as long as the pH is

    acceptable

  • 8/14/2019 Peds Clinical Cases (Egypt) 3-09 (Final Version)

    14/57

    Permissive HypercapniaPermissive Hypercapnia Available data support permissive hypercapnia to

    minimize vent settings and secondary lung injury

    Goal: maintain acceptable pH regardless of PaCO2

    Contraindications

    increased intracranial pressure reactive pulmonary hypertension

    Acute lung injury model (Laffey, AJRCCM, 2000)

    hypercapnic acidosis is protective

    buffering attenuates its protective effects

    Available data support permissive hypercapnia to

    minimize vent settings and secondary lung injury

    Goal: maintain acceptable pH regardless of PaCO2

    Contraindications

    increased intracranial pressure reactive pulmonary hypertension

    Acute lung injury model (Laffey, AJRCCM, 2000)

    hypercapnic acidosis is protectivehypercapnic acidosis is protective

    buffering attenuates its protective effectsbuffering attenuates its protective effects

  • 8/14/2019 Peds Clinical Cases (Egypt) 3-09 (Final Version)

    15/57

    Question #4

    What is the goal SaO2 for yourpatient?

    Question #4

    What is the goal SaO2 for yourpatient?

    A. 95%B. 90 94%

    C. 85 89%

    D. 80 84%

    E. < 80%

    A.A.

    95%95%B.B. 9090 94%94%

    C.C. 8585 89%89%

    D.D. 8080 84%84%

    E.E. < 80%< 80%

  • 8/14/2019 Peds Clinical Cases (Egypt) 3-09 (Final Version)

    16/57

    Permissive HypoxemiaPermissive Hypoxemia Definitive data are lacking in the medical

    literature!

    Goal maintain a safe level of oxygenation

    Maintain adequate O2 delivery

    optimize cardiac output measure ABG / MVO2 / serum lactate

    Assess end-organ function

    mental status (difficult 2 sedation)

    renal function / urine output

    cardiac function

    Definitive data are lacking in the medical

    literature!

    Goal maintain a safe level of oxygenation

    Maintain adequate O2 delivery

    optimize cardiac output measure ABG / MVO2 / serum lactate

    Assess end-organ function

    mental status (difficult 2 sedation)

    renal function / urine output

    cardiac function

  • 8/14/2019 Peds Clinical Cases (Egypt) 3-09 (Final Version)

    17/57

    Question #5

    Do you routinely use recruitmentmaneuvers (i.e., sustained inflation)

    for pediatric ALI / ARDS?

    Question #5

    Do you routinely use recruitmentmaneuvers (i.e., sustained inflation)

    for pediatric ALI / ARDS?A. Yes

    B. No

    A.A. YesYes

    B.B. NoNo

  • 8/14/2019 Peds Clinical Cases (Egypt) 3-09 (Final Version)

    18/57

    Recruitment ManeuversRecruitment Maneuvers Use of RMs remains controversial.

    Bring lung to TLC to maximize recruitment,then move down the deflation limb of the

    pressure-volume curve to an appropriate

    PEEP to prevent de-recruitment No adult outcome data

    No pediatric data

    Use of RMs remains controversial.Use of RMs remains controversial.

    Bring lung to TLC to maximize recruitment,Bring lung to TLC to maximize recruitment,

    then move down the deflation limb of thethen move down the deflation limb of the

    pressurepressure--volume curve to anvolume curve to an appropriateappropriate

    PEEP to prevent dePEEP to prevent de

    --recruitmentrecruitment

    No adult outcome data

    No pediatric data

  • 8/14/2019 Peds Clinical Cases (Egypt) 3-09 (Final Version)

    19/57

    Should RMs be routinely performed foradult ARDS pts?

    12 Experts

    Yes 3

    No 9

    Abstain 1

    Should RMs be routinely performed foradult ARDS pts?

    12 Experts

    Yes 3

    No 9

    Abstain 1

  • 8/14/2019 Peds Clinical Cases (Egypt) 3-09 (Final Version)

    20/57

  • 8/14/2019 Peds Clinical Cases (Egypt) 3-09 (Final Version)

    21/57

    Case 2: TraumaCase 2: Trauma 3 year old unrestrained passenger ejected

    from car

    Intubated for loss of consciousness

    Transported to ED

    GCS 5, poorly perfused bruising noted over left chest wall

    SpO2 83%; FiO2 1.0

    ABG pH 7.25 PaCO2 32 PaO2 43 BE -9

    Trauma eval and stabilization in

    Emergency Department then to PICU

    3 year old unrestrained passenger ejected3 year old unrestrained passenger ejected

    from carfrom car

    Intubated for loss of consciousnessIntubated for loss of consciousness

    Transported to EDTransported to ED

    GCS 5GCS 5, poorly perfused, poorly perfused bruising noted over left chest wallbruising noted over left chest wall

    SpOSpO22 83%; FiO83%; FiO22 1.01.0

    ABG pH 7.25 PaCOABG pH 7.25 PaCO22 32 PaO32 PaO22 43 BE43 BE --99

    Trauma eval and stabilization inTrauma eval and stabilization in

    Emergency Department then to PICUEmergency Department then to PICU

  • 8/14/2019 Peds Clinical Cases (Egypt) 3-09 (Final Version)

    22/57

    Pulm ContusionPulm Contusion

    Patient placed on ventilator in PRVC mode

    Vt 7 ml/kg rate 20 PIP 31 PEEP 8

    FiO2 0.70

    ABG pH 7.34 PaCO2 41 PaO2 43

    Patient placed on ventilator in PRVC modePatient placed on ventilator in PRVC mode

    Vt 7 ml/kg rate 20 PIP 31 PEEP 8Vt 7 ml/kg rate 20 PIP 31 PEEP 8

    FiOFiO22 0.700.70

    ABG pH 7.34 PaCOABG pH 7.34 PaCO22 41 PaO41 PaO22 4343

  • 8/14/2019 Peds Clinical Cases (Egypt) 3-09 (Final Version)

    23/57

    Question #6

    Would you administer exogenoussurfactant?

    Question #6

    Would you administer exogenoussurfactant?

    A. Within the first 48 hours

    B. If no improvement after 48 hours

    C. If no improvement after 7 daysD. Not for this patient

    A.A. Within the first 48 hoursWithin the first 48 hours

    B.B. If no improvement after 48 hoursIf no improvement after 48 hours

    C.C. If no improvement after 7 daysIf no improvement after 7 daysD.D. Not for this patientNot for this patient

  • 8/14/2019 Peds Clinical Cases (Egypt) 3-09 (Final Version)

    24/57

    Exogenous SurfactantExogenous Surfactant Exogenous surfactant administration is the

    only adjunct therapy that has been shown to

    be beneficial for the pediatric ALI / ARDS pt.

    Willson, JAMA, 2005

    Surfactant was shown to be beneficial whenadministered within 48 hours of onset of ALI.

    Exogenous surfactant administration is the

    only adjunct therapy that has been shown to

    be beneficial for the pediatric ALI / ARDS pt.

    Willson, JAMA, 2005

    Surfactant was shown to be beneficial whenadministered within 48 hours of onset of ALI.

  • 8/14/2019 Peds Clinical Cases (Egypt) 3-09 (Final Version)

    25/57

    Question #7

    Would you offer a trial of inhalednitric oxide?

    Question #7

    Would you offer a trial of inhalednitric oxide?

    A. Within the first 48 hoursB. If no improvement after 48 hours

    C. If no improvement after 7 daysD. Not for this patient

    A.A. Within the first 48 hoursWithin the first 48 hoursB.B. If no improvement after 48 hoursIf no improvement after 48 hours

    C.C. If no improvement after 7 daysIf no improvement after 7 daysD.D. Not for this patientNot for this patient

  • 8/14/2019 Peds Clinical Cases (Egypt) 3-09 (Final Version)

    26/57

    Question #8

    When would you consider a trialof prone positioning?

    Question #8

    When would you consider a trialof prone positioning?

    A. Within the first 48 hoursB. If no improvement after 48 hours

    C. If no improvement after 7 daysD. Not for this patient

    A.A. Within the first 48 hoursWithin the first 48 hoursB.B. If no improvement after 48 hoursIf no improvement after 48 hours

    C.C. If no improvement after 7 daysIf no improvement after 7 daysD.D. Not for this patientNot for this patient

  • 8/14/2019 Peds Clinical Cases (Egypt) 3-09 (Final Version)

    27/57

    Inhaled NO / Prone PositionInhaled NO / Prone Position Multiple studies have demonstrated improved

    oxygenation for adult and pediatric patients

    with the administration of inhaled nitric oxideand prone positioning for acute lung injury.

    But, no study has demonstrated improvedsurvival with either therapy for acute lung

    injury.

    Multiple studies have demonstrated improved

    oxygenation for adult and pediatric patients

    with the administration of inhaled nitric oxideand prone positioning for acute lung injury.

    But, no study has demonstrated improvedsurvival with either therapy for acute lung

    injury.

    Inhaled Nitric OxideDobyns, Pediatr, 1999

    Dellinger, Crit Care Med, 1998

    Inhaled Nitric Oxide

    Dobyns, Pediatr, 1999

    Dellinger, Crit Care Med, 1998

    Prone PositioningCurley, JAMA, 2005

    Guerin, JAMA, 2004

    Gattinoni, NEJM, 2001

    Prone Positioning

    Curley, JAMA, 2005

    Guerin, JAMA, 2004

    Gattinoni, NEJM, 2001

  • 8/14/2019 Peds Clinical Cases (Egypt) 3-09 (Final Version)

    28/57

    Question #9

    At what settings would you initiateHFOV?

    Question #9

    At what settings would you initiateHFOV?

    A. OI 17, MAP 18, PIP 30, FiO2 50%B. OI 22, MAP 22, PIP 32, FiO2 65%

    C. OI 38, MAP 27, PIP 37, FiO2 80%

    D. Would not use HFOV

    A.A. OI 17, MAP 18, PIP 30, FiOOI 17, MAP 18, PIP 30, FiO22 50%50%B.B. OI 22, MAP 22, PIP 32, FiOOI 22, MAP 22, PIP 32, FiO22 65%65%

    C.C. OI 38, MAP 27, PIP 37, FiOOI 38, MAP 27, PIP 37, FiO22 80%80%

    D.D. Would not use HFOVWould not use HFOV

  • 8/14/2019 Peds Clinical Cases (Egypt) 3-09 (Final Version)

    29/57

    Pediatric HFOVPediatric HFOV

    Arnold, Crit Care Med, 1994.Arnold, Crit Care Med, 1994.

  • 8/14/2019 Peds Clinical Cases (Egypt) 3-09 (Final Version)

    30/57

    DISCUSSIONDISCUSSION

  • 8/14/2019 Peds Clinical Cases (Egypt) 3-09 (Final Version)

    31/57

    Case 3: Status AsthmaticusCase 3: Status Asthmaticus 12 year old female with known history of asthma

    PMHx: 2 prior PICU admits; never intubated

    On ED arrival

    obvious respiratory distress

    SpO2 84% (RA); BP 110/57; HR 142; RR 48

    Triage nurses rushes patient to a room and

    STAT pages you

    12 year old female with known history of asthma12 year old female with known history of asthma

    PMHx: 2 prior PICU admits; never intubatedPMHx: 2 prior PICU admits; never intubated

    On ED arrivalOn ED arrival

    obvious respiratory distressobvious respiratory distress

    SpOSpO22 84% (RA); BP 110/57; HR 142; RR 4884% (RA); BP 110/57; HR 142; RR 48

    Triage nurses rushes patient to a room andTriage nurses rushes patient to a room and

    STAT pages youSTAT pages you

  • 8/14/2019 Peds Clinical Cases (Egypt) 3-09 (Final Version)

    32/57

    Initial ManagementInitial Management Your initial assessment

    SpO2 85% (RA); HR 151; RR 54

    distant wheezing

    poor air exchange

    moderate subcostal & intercostal retractions

    FiO2 via face mask started at 0.60

    Solumedrol (1 mg/kg) IV ordered

    Your initial assessmentYour initial assessment

    SpOSpO22 85% (RA); HR 151; RR 5485% (RA); HR 151; RR 54

    distant wheezingdistant wheezing

    poor air exchangepoor air exchange

    moderate subcostal & intercostal retractionsmoderate subcostal & intercostal retractions

    FiOFiO22 via face mask started at 0.60via face mask started at 0.60

    Solumedrol (1 mg/kg) IV orderedSolumedrol (1 mg/kg) IV ordered

  • 8/14/2019 Peds Clinical Cases (Egypt) 3-09 (Final Version)

    33/57

    Question #10

    Which of the following would youdo next?

    Question #10

    Which of the following would youdo next?

    A. Obtain an ABG

    B. Start continuous albuterol at 20 mg/hr

    C. Start continuous albuterol at 40 mg/hr

    D. Start non-invasive ventilation

    E. Emergently intubate

    A.A. Obtain an ABGObtain an ABG

    B.B. Start continuous albuterol at 20 mg/hrStart continuous albuterol at 20 mg/hr

    C.C. Start continuous albuterol at 40 mg/hrStart continuous albuterol at 40 mg/hr

    D.D. Start nonStart non--invasive ventilationinvasive ventilation

    E.E. Emergently intubateEmergently intubate

  • 8/14/2019 Peds Clinical Cases (Egypt) 3-09 (Final Version)

    34/57

    Status AsthmaticusStatus Asthmaticus

    Continuous albuterol started at 40 mg/hr

    Patient initially with improved air exchange on

    auscultation

    Continues to have increased WOB but slightly

    improved Intern sends med student to obtain ABG

    obviously unsuccessful

    Patient now complains that she cannot

    breathe

    Continuous albuterol started at 40 mg/hrContinuous albuterol started at 40 mg/hr

    Patient initially with improved air exchange onPatient initially with improved air exchange on

    auscultationauscultation

    Continues to have increased WOB but slightlyContinues to have increased WOB but slightly

    improvedimproved Intern sends med student to obtain ABGIntern sends med student to obtain ABG

    obviously unsuccessfulobviously unsuccessful

    Patient now complains that she cannot

    breathe

  • 8/14/2019 Peds Clinical Cases (Egypt) 3-09 (Final Version)

    35/57

    Question #11

    Would you offer a trial of heliox beforeintubation?

    Question #11

    Would you offer a trial of heliox beforeintubation?

    A. Yes

    B. No

    A.A. YesYes

    B.B. NoNo

  • 8/14/2019 Peds Clinical Cases (Egypt) 3-09 (Final Version)

    36/57

    Gas DensitiesGas Densities

    Relative density of He-O2 and N2-O2

    mixtures compared with 100% O2.

    Relative density of He-O2 and N2-O2

    mixtures compared with 100% O2.

    Oppenheim-Eden, Chest, 2001.Oppenheim-Eden, Chest, 2001.

  • 8/14/2019 Peds Clinical Cases (Egypt) 3-09 (Final Version)

    37/57

    Principles of Gas FlowPrinciples of Gas Flow

    Because of its lower density than N2 or O2,

    heliox would be predicted to improve gas

    flow through a narrowed orifice.

    Reynolds number (Re = VD / )

    Re > 4000 = turbulent flow Re < 2100 = laminar flow

    Because of its lower density than N2 or O2,

    heliox would be predicted to improve gas

    flow through a narrowed orifice.

    Reynolds number (Re = VD / )

    Re > 4000 = turbulent flow Re < 2100 = laminar flow

  • 8/14/2019 Peds Clinical Cases (Egypt) 3-09 (Final Version)

    38/57

    Turbulent Gas FlowTurbulent Gas Flow

    Occurs in constricted passages

    Flow rate = k P

    gas density yields gas flow.

    Thus, heliox improves turbulent gas

    flow.

    Occurs in constricted passages

    Flow rate = k P

    gas density yields gas flow.

    Thus, heliox improves turbulent gas

    flow.

  • 8/14/2019 Peds Clinical Cases (Egypt) 3-09 (Final Version)

    39/57

    Asthma and HelioxAsthma and Heliox

    Both groups received methylprednisolone 125 mg IV

    inhaled albuterol 2.5 mg nebs x 2

    After 20 minutes of therapy

    Heliox group PEF 58.4% N2-O2 group PEF 10.1%

    Both groups received methylprednisolone 125 mg IV

    inhaled albuterol 2.5 mg nebs x 2

    After 20 minutes of therapy

    Heliox group PEF 58.4% N2-O2 group PEF 10.1%

    Kass, Chest, 1999.Kass, Chest, 1999.

  • 8/14/2019 Peds Clinical Cases (Egypt) 3-09 (Final Version)

    40/57

    Asthma and HelioxAsthma and Heliox

    Kass, Chest, 1999.Kass, Chest, 1999.

  • 8/14/2019 Peds Clinical Cases (Egypt) 3-09 (Final Version)

    41/57

    A-a GradientA-a Gradient

    Schaeffer, CCM, 1999.Schaeffer, CCM, 1999.

    0

    50

    100

    150

    200

    250

    300

    0

    50

    100

    150

    200

    250

    300

    * p= 0.003* p= 0.003

    BaselineBaseline 2 hrs2 hrs

    **

    controlhelioxcontrolheliox

  • 8/14/2019 Peds Clinical Cases (Egypt) 3-09 (Final Version)

    42/57

    Asthma and OxygenationAsthma and Oxygenation

    FiO2 in the heliox treated group

    decreased from 0.810.25 to

    0.370.27 after 2 hours of therapy.

    (p= 0.0008)

    This study rejects the idea that aminimum of 40% helium must be

    used to obtain a therapeutic effect.

    FiO2 in the heliox treated group

    decreased from 0.810.25 to

    0.370.27 after 2 hours of therapy.

    (p= 0.0008)

    This study rejects the idea that aminimum of 40% helium must be

    used to obtain a therapeutic effect.

    Schaeffer, CCM, 1999.Schaeffer, CCM, 1999.

  • 8/14/2019 Peds Clinical Cases (Egypt) 3-09 (Final Version)

    43/57

    The Spiral EffectThe Spiral Effect

    some

    heliox

    some

    heliox

    improve gas

    exchange

    improve gas

    exchange

    decrease

    FiO2

    decrease

    FiO2

    increase

    heliox

    concentration

    increase

    heliox

    concentration

  • 8/14/2019 Peds Clinical Cases (Egypt) 3-09 (Final Version)

    44/57

    But.But. What if your patient does not improve with heliox

    or if you do not have heliox at your institution?

    Then, probably intubate. Patient intubated with 6.5 cuffed ETT without

    difficulty (not by the med student)

    Patient is being hand ventilated with FiO2 1.0.

    Patient is transferred to the PICU.

    What if your patient does not improve with heliox

    or if you do not have heliox at your institution?

    Then, probably intubate.Then, probably intubate. Patient intubated with 6.5 cuffed ETT withoutPatient intubated with 6.5 cuffed ETT without

    difficulty (not by the med student)difficulty (not by the med student)

    Patient is being hand ventilated with FiOPatient is being hand ventilated with FiO2 1.0.1.0.

    Patient is transferred to the PICU.Patient is transferred to the PICU.

  • 8/14/2019 Peds Clinical Cases (Egypt) 3-09 (Final Version)

    45/57

    Question #12

    What ventilator mode would bemost appropriate?

    Question #12

    What ventilator mode would bemost appropriate?

    A. Volume control with square waveform

    B. Pressure control with variable flow

    C. PRVC with variable flowD. High frequency ventilation

    A.A. Volume control with square waveformVolume control with square waveform

    B.B. Pressure control with variable flowPressure control with variable flow

    C.C. PRVC with variable flowPRVC with variable flowD.D. High frequency ventilationHigh frequency ventilation

  • 8/14/2019 Peds Clinical Cases (Egypt) 3-09 (Final Version)

    46/57

    Pressure ScalarPressure Scalar

    Pressure(cm H2O)Pressure(cm H2O)

    Constant,

    Square Wave

    Constant,

    Square WaveVariable,

    Decelerating Wave

    Variable,

    Decelerating Wave

    00

    PIPPIP

    PawPaw

    Q #13

  • 8/14/2019 Peds Clinical Cases (Egypt) 3-09 (Final Version)

    47/57

    Question #13

    Which of the following settingswould you use?

    Question #13

    Which of the following settingswould you use?

    A. Vt 12 ml/kg, rate 12, PEEP 5

    B. Vt 8 ml/kg, rate 18, PEEP 5

    C. Vt 6 ml/kg, rate 24, PEEP 5

    A.A. Vt 12 ml/kg, rate 12, PEEP 5Vt 12 ml/kg, rate 12, PEEP 5

    B.B. Vt 8 ml/kg, rate 18, PEEP 5Vt 8 ml/kg, rate 18, PEEP 5

    C.C. Vt 6 ml/kg, rate 24, PEEP 5Vt 6 ml/kg, rate 24, PEEP 5

  • 8/14/2019 Peds Clinical Cases (Egypt) 3-09 (Final Version)

    48/57

    Asthma and Mech VentilationAsthma and Mech Ventilation

    6 ml/kg has been shown to be the ideal tidal

    volume only for adult ALI / ARDS.

    Use long expiratory time ventilation which oftenrequires a larger tidal volume and low set

    ventilatory rate.

    Goal should be to transition to Pressure SupportVentilation with goal of extubation as soon as

    possible.

    6 ml/kg has been shown to be the ideal tidal

    volume only for adult ALI / ARDS.

    Use long expiratory time ventilation which oftenUse long expiratory time ventilation which oftenrequires arequires a largerlarger tidal volume and low settidal volume and low set

    ventilatory rate.ventilatory rate.

    Goal should be to transition to Pressure SupportGoal should be to transition to Pressure SupportVentilation with goal of extubation as soon asVentilation with goal of extubation as soon as

    possible.possible.

  • 8/14/2019 Peds Clinical Cases (Egypt) 3-09 (Final Version)

    49/57

    DISCUSSIONDISCUSSION

    Case 4:Case 4:

  • 8/14/2019 Peds Clinical Cases (Egypt) 3-09 (Final Version)

    50/57

    Case 4:

    Patient-Ventilator Interactions

    Case 4:

    Patient-Ventilator Interactions 10 mo old infant; 28 weeks prematurity

    Intubated for viral pneumonia

    HR 172, RR 65, BP 82/45, afebrile

    SIMV / PS rate 24, PIP 28, PEEP 7, FiO2 0.50

    ABG: pH 7.25 / PaCO2 64 / PaO2 68

    Infant is very agitated

    Nurse requests additional sedation/analgesia

    10 mo old infant; 28 weeks prematurity10 mo old infant; 28 weeks prematurity

    Intubated for viral pneumoniaIntubated for viral pneumonia

    HR 172, RR 65, BP 82/45, afebrileHR 172, RR 65, BP 82/45, afebrile

    SIMV / PSSIMV / PS rate 24, PIP 28, PEEP 7, FiOrate 24, PIP 28, PEEP 7, FiO22 0.500.50

    ABG: pH 7.25 / PaCOABG: pH 7.25 / PaCO22 64 / PaO64 / PaO22 6868

    Infant is very agitatedInfant is very agitated

    Nurse requests additional sedation/analgesiaNurse requests additional sedation/analgesia

  • 8/14/2019 Peds Clinical Cases (Egypt) 3-09 (Final Version)

    51/57

    Question #14Question #14

  • 8/14/2019 Peds Clinical Cases (Egypt) 3-09 (Final Version)

    52/57

    Question #14

    Why is the patient agitated?

    Question #14

    Why is the patient agitated?A. Inadequate sedation / analgesia

    B. Trigger insensitivityC. Flow dys-synchrony

    D. Inadequate PEEP

    E. Inadequate tidal volume

    A.A. Inadequate sedation / analgesiaInadequate sedation / analgesia

    B.B. Trigger insensitivityTrigger insensitivityC.C. Flow dysFlow dys--synchronysynchrony

    D.D. Inadequate PEEPInadequate PEEP

    E.E. Inadequate tidal volumeInadequate tidal volume

  • 8/14/2019 Peds Clinical Cases (Egypt) 3-09 (Final Version)

    53/57

  • 8/14/2019 Peds Clinical Cases (Egypt) 3-09 (Final Version)

    54/57

    Question #15Question #15

  • 8/14/2019 Peds Clinical Cases (Egypt) 3-09 (Final Version)

    55/57

    Question #15

    Why is the patient agitated?

    Question #15

    Why is the patient agitated?A. Inadequate sedation / analgesia

    B. Trigger insensitivity

    C. Flow dys-synchrony

    D. Inadequate PEEP

    E. Inadequate tidal volume

    A.A. Inadequate sedation / analgesiaInadequate sedation / analgesia

    B.B. Trigger insensitivityTrigger insensitivity

    C.C. Flow dysFlow dys--synchronysynchrony

    D.D. Inadequate PEEPInadequate PEEP

    E.E. Inadequate tidal volumeInadequate tidal volume

  • 8/14/2019 Peds Clinical Cases (Egypt) 3-09 (Final Version)

    56/57

    DISCUSSIONDISCUSSION

  • 8/14/2019 Peds Clinical Cases (Egypt) 3-09 (Final Version)

    57/57

    DISCUSSIONDISCUSSION